Valneva SE (VALN) Gross Profit (QoQ) (2021 - 2026)
Powered by 
Analysis
Valneva SE (VALN) Gross Profit (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Valneva SE | 581.90 Mn | 440.64 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -66.39% |
| Mar 31, 2026 | -59.10% |
| Dec 31, 2025 | 110.20% |
| Sep 30, 2025 | -76.53% |
| Jun 30, 2025 | -0.52% |
| Mar 31, 2025 | 0.27% |
| Dec 31, 2024 | 24.18% |
| Sep 30, 2024 | 40.80% |
| Jun 30, 2024 | 36.55% |
| Mar 31, 2024 | -32.45% |
| Dec 31, 2023 | -8.47% |
| Sep 30, 2023 | 148.56% |
| Jun 30, 2023 | -46.45% |
| Mar 31, 2023 | 232.89% |
| Dec 31, 2022 | -108.32% |
| Sep 30, 2022 | 237.43% |
| Jun 30, 2022 | -1,126.59% |
| Mar 31, 2022 | -96.86% |
| Dec 31, 2021 | 336.59% |
| Sep 30, 2021 | -2,512.53% |